233 related articles for article (PubMed ID: 10466633)
1. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
[TBL] [Abstract][Full Text] [Related]
2. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
[TBL] [Abstract][Full Text] [Related]
3. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.
Kievit E; Bershad E; Ng E; Sethna P; Dev I; Lawrence TS; Rehemtulla A
Cancer Res; 1999 Apr; 59(7):1417-21. PubMed ID: 10197605
[TBL] [Abstract][Full Text] [Related]
4. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.
Nyati MK; Symon Z; Kievit E; Dornfeld KJ; Rynkiewicz SD; Ross BD; Rehemtulla A; Lawrence TS
Gene Ther; 2002 Jul; 9(13):844-9. PubMed ID: 12080378
[TBL] [Abstract][Full Text] [Related]
5. Combined radiation and enzyme/prodrug treatment for head and neck cancer in an orthotopic animal model.
Hamstra DA; Rice DJ; Pu A; Oyedijo D; Ross BD; Rehemtulla A
Radiat Res; 1999 Nov; 152(5):499-507. PubMed ID: 10521927
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
7. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
[TBL] [Abstract][Full Text] [Related]
8. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.
Stegman LD; Rehemtulla A; Hamstra DA; Rice DJ; Jonas SJ; Stout KL; Chenevert TL; Ross BD
Gene Ther; 2000 Jun; 7(12):1005-10. PubMed ID: 10871748
[TBL] [Abstract][Full Text] [Related]
9. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
[TBL] [Abstract][Full Text] [Related]
10. Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene.
Gabel M; Kim JH; Kolozsvary A; Khil M; Freytag S
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):883-7. PubMed ID: 9652853
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications.
Johnson AJ; Ardiani A; Sanchez-Bonilla M; Black ME
Cancer Gene Ther; 2011 Aug; 18(8):533-42. PubMed ID: 21394105
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
[TBL] [Abstract][Full Text] [Related]
13. Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine.
Li JJ; Chang SF; Liau II; Chan PC; Liu RS; Yen SH; Wang HE; Chang CA
J Biomed Sci; 2016 Jan; 23():15. PubMed ID: 26801910
[TBL] [Abstract][Full Text] [Related]
14. Transduction of yeast cytosine deaminase mediated by HIV-1 Tat basic domain into tumor cells induces chemosensitivity to 5-fluorocytosine.
Lee H; Ryu J; Kim KA; Lee KS; Lee JY; Park JB; Park J; Choi SY
Exp Mol Med; 2004 Feb; 36(1):43-51. PubMed ID: 15031670
[TBL] [Abstract][Full Text] [Related]
15. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
[TBL] [Abstract][Full Text] [Related]
16. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer.
Nyati MK; Sreekumar A; Li S; Zhang M; Rynkiewicz SD; Chinnaiyan AM; Rehemtulla A; Lawrence TS
Cancer Res; 2002 Apr; 62(8):2337-42. PubMed ID: 11956093
[TBL] [Abstract][Full Text] [Related]
17. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
[TBL] [Abstract][Full Text] [Related]
18. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
19. Human nerve growth factor receptor and cytosine deaminase fusion genes.
Lewis VA; Basso L; Blake N; Salo J; Lund TC; McIvor RS; Orchard PJ
Hum Gene Ther; 2003 Jul; 14(10):1009-16. PubMed ID: 12869218
[TBL] [Abstract][Full Text] [Related]
20. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
Pierrefite-Carle V; BaquƩ P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]